GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
Doctor, implant contraceptive has changed my menses pattern, am I in danger?
Dear Doctor, I’m 38 and a mother of two. I’m separated but I have a boy friend. Two months ago, I went to the health centre to replace my in-plant.
WHO declares COVID-19 as a pandemic
Says it would be the first pandemic in history to be controlled. The World Health Organisation (WHO) yesterday (March 11) declared the global spread of Coronavirus (COVID-19) as a pandemic.
How we rebranded NPHCDA for better services – Executive-Director
… Says 4,000 PHCs revitalized …Pledges increased access to functional PHCs in 2019 Marcus Fatunmole (Abuja) The Executive-Director, National Primary Health Care Development Agency (NPHCDA) Dr Faisal Shuaib, has said
0 Comments
No Comments Yet!
You can be first to comment this post!